GlassScriptPhysician profile
Kurt V Gold
NPI 1538189055
$8,261.33
in general payments reported to CMS, 2019-2025
46 companies · $1,132 in 2025
The $1,132 reported for 2025 was more than what 89% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $917 · 2020: $860 · 2021: $1,444 · 2022: $1,119 · 2023: $751 · 2024: $2,039 · 2025: $1,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,385 · Education: $1,536.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,385.42 |
| Education | $1,536.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $1,525.30 | 2024 | Prialt |
| Collegium Pharmaceutical, INC. | $807.52 | 2019-2025 | Xtampza, Belbuca |
| Lilly USA, LLC | $698.91 | 2019-2025 | Emgality, Zepbound, Mounjaro |
| Abbvie INC. | $519.29 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $390.13 | 2019-2024 | Relistor |
| Gilead Sciences, INC. | $342.53 | 2020-2023 | |
| Currax Pharmaceuticals LLC | $326.44 | 2020-2023 | Onzetra Xsail |
| Pfizer INC. | $321.72 | 2019-2025 | |
| Scilex Pharmaceuticals INC. | $281.66 | 2019-2023 | Ztlido |
| Allergan, INC. | $243.94 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $232.31 | 2020-2022 | |
| Vertex Pharmaceuticals Incorporated | $229.16 | 2025 | |
| Protega Pharmaceutials INC | $200.63 | 2025 | Roxybond |
| Takeda Pharmaceuticals U.S.A., INC. | $189.58 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $183.40 | 2021 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Gold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.